Search

everythinglearnresearchcommunity

for

Search:↓

The patient with severe hirsutism improved after being diagnosed with non-classic congenital adrenal hyperplasia and treated with corticosteroids.

The combination treatment reduced prostate size and improved testosterone deficiency symptoms but was less effective for sexual function.

Increasing COX-2 in mouse skin causes bigger sebaceous glands and thinner hair, but stopping COX-2 can reverse hair thinning.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

Hyaluronic acid filler and fat grafting can cause rare skin complications.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Removing PLCg1 from skin cells caused thicker oil glands and less hair in mice.

Congenital Adrenal Hyperplasia is mainly caused by enzyme deficiencies, leading to varying symptoms like hormone imbalances and physical changes.

BPH treatment improved with personalized medicine, new drugs, and less invasive surgeries.

Higher CRP levels suggest chronic inflammation is linked to bladder-related urinary symptoms in men with enlarged prostates.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Urinary PSA could be an early marker for enlarged prostate.

A patient with congenital adrenal hyperplasia improved after adjusting her medication to prevent Cushing's syndrome symptoms.

Nonclassic congenital adrenal hyperplasia is a common genetic disorder that can cause a range of symptoms and requires personalized treatment.

Dutasteride effectively treats benign prostatic hyperplasia, improving symptoms and quality of life.

New genotype linked to non-classical congenital adrenal hyperplasia found in Italian siblings.

Finasteride reduces prostate cancer risk but may increase high-grade cancer cases.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Middle-aged and elderly men with BPH had higher hospitalization rates for COVID-19.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Hair loss linked to prostate enlargement; stress and family history important factors.

There is no link between hair loss and prostate enlargement.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Hair loss can be an early sign of prostate enlargement.

People with early-onset hair loss (AGA) have a higher risk of heart disease, metabolic syndrome, and prostate enlargement.

Gene variation affects prostate issues and hair loss.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

More men are getting benign prostatic hyperplasia, and there are many treatments, from medication to surgery, with new methods being developed.

Medications have become the main treatment for enlarged prostate symptoms, replacing surgery and watchful waiting.